首页> 外文期刊>Arthritis & rheumatology. >Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis
【24h】

Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis

机译:甲氨蝶呤通过类风湿性关节炎患者FoxP3上游增强子的去甲基化恢复调节性T细胞功能。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective. We have previously shown, in a cohort of untreated rheumatoid arthritis (RA) patients, that the suppressive function of Treg cells is defective. However, other studies in cohorts of patients with established RA have shown that Treg cell function is normal. We hypothesized that treatment may restore Treg cell function and lead to reduced disease activity. The aim of this study was to investigate whether treatment with methotrexate (MTX) can result in epigenetic changes that lead to restoration of the Treg cell suppressive function in RA.
机译:目的。先前我们在未治疗的类风湿关节炎(RA)患者队列中显示,Treg细胞的抑制功能存在缺陷。但是,其他对已确诊为RA的患者的研究表明Treg细胞功能正常。我们假设治疗可以恢复Treg细胞功能并导致疾病活动减少。这项研究的目的是调查甲氨蝶呤(MTX)的治疗是否可以导致表观遗传学改变,从而导致RA中Treg细胞抑制功能的恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号